Sage Journals: Discover world-class research

Free access

Review article

First published 2016-10

The potential of venetoclax (ABT-199) in chronic lymphocytic leukemia

Gilad Itchaki, Jennifer R. Brown

Therapeutic Advances in Hematology

Free access

Research article

First published 2023-10

High-Throughput Drug Screen for Potential Combinations With Venetoclax Guides the Treatment of Transformed Follicular Lymphoma

Zhifeng Li, Guangchao Pan, Mengya Zhong [...]

International Journal of Toxicology

Retricted access

Research article

First published 2018-2

Safety and pharmacodynamics of venetoclax (ABT-199) in a randomized single and multiple ascending dose study in women with systemic lupus erythematosus

P Lu, R Fleischmann, C Curtis [...]

Lupus

Open access

Research article

First published 2023-4

A cross-sectional survey of English NHS Trusts on their uptake and provision of active bystander training including to address sexual harassment

Ava Robertson, Sarah Steele

JRSM Open

Free access

Research article

First published 2014-8

Identification of Small Inhibitory Molecules Targeting the Bfl-1 Anti-Apoptotic Protein That Alleviates Resistance to ABT-737

Anne-Laure Mathieu, Olivier Sperandio, Virginie Pottiez [...]

Journal of Biomolecular Screening

Retricted access

Review article

First published 2017-5

Venetoclax: A First-in-Class Oral BCL-2 Inhibitor for the Management of Lymphoid Malignancies

Amber C. King, Tim J. Peterson, Troy Z. Horvat [...]

Annals of Pharmacotherapy

Retricted access

Research article

First published 2017-10

Expanding the armamentarium for chronic lymphocytic leukemia: A review of novel agents in the management of chronic lymphocytic leukemia

Bernard L Marini, Lisa Samanas, Anthony J Perissinotti

Journal of Oncology Pharmacy Practice

Search results

The potential of venetoclax (ABT-199) in chronic lymphocytic leukemia

High-Throughput Drug Screen for Potential Combinations With Venetoclax Guides the Treatment of Transformed Follicular Lymphoma

Safety and pharmacodynamics of venetoclax (ABT-199) in a randomized single and multiple ascending dose study in women with systemic lupus erythematosus

A cross-sectional survey of English NHS Trusts on their uptake and provision of active bystander training including to address sexual harassment

Identification of Small Inhibitory Molecules Targeting the Bfl-1 Anti-Apoptotic Protein That Alleviates Resistance to ABT-737

Venetoclax: A First-in-Class Oral BCL-2 Inhibitor for the Management of Lymphoid Malignancies

Expanding the armamentarium for chronic lymphocytic leukemia: A review of novel agents in the management of chronic lymphocytic leukemia